de Invesco ANI Pharmaceuticals ANIP Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 25.6 M | Vender |
309,233
-15,116
| -5% | -USD 1.21 M | ﹤0.01% | 1396 |
|
|
2026
Q1 | USD 24.9 M | Comprar |
324,349
+134,513
| +71% | +USD 10.5 M | ﹤0.01% | 1351 |
|
|
2025
Q4 | USD 15 M | Comprar |
189,836
+39,178
| +26% | +USD 3.39 M | ﹤0.01% | 1614 |
|
|
2025
Q3 | USD 13.8 M | Vender |
150,658
-21,799
| -13% | -USD 1.78 M | ﹤0.01% | 1637 |
|
|
2025
Q2 | USD 11.3 M | Vender |
172,457
-27,110
| -14% | -USD 1.77 M | ﹤0.01% | 1702 |
|
|
2025
Q1 | USD 13.4 M | Comprar |
199,567
+2,022
| +1% | +USD 121 k | ﹤0.01% | 1626 |
|
|
2024
Q4 | USD 10.9 M | Vender |
197,545
-22,814
| -10% | -USD 1.31 M | ﹤0.01% | 1800 |
|
|
2024
Q3 | USD 13.1 M | Vender |
220,359
-90,732
| -29% | -USD 5.54 M | ﹤0.01% | 1699 |
|
|
2024
Q2 | USD 19.8 M | Vender |
311,091
-12,951
| -4% | -USD 841 k | ﹤0.01% | 1440 |
|
|
2024
Q1 | USD 22.4 M | Comprar |
324,042
+65,596
| +25% | +USD 3.96 M | ﹤0.01% | 1382 |
|
|
2023
Q4 | USD 14.3 M | Vender |
258,446
-81,289
| -24% | -USD 4.48 M | ﹤0.01% | 1600 |
|
|
2023
Q3 | USD 19.7 M | Comprar |
339,735
+220,690
| +185% | +USD 12.7 M | 0.01% | 1342 |
|
|
2023
Q2 | USD 6.41 M | Comprar |
119,045
+52,953
| +80% | +USD 2.35 M | ﹤0.01% | 2101 |
|
|
2023
Q1 | USD 2.63 M | Vender |
66,092
-6,385
| -9% | -USD 269 k | ﹤0.01% | 2526 |
|
|
2022
Q4 | USD 2.92 M | Comprar |
72,477
+6,603
| +10% | +USD 248 k | ﹤0.01% | 2494 |
|
|
2022
Q3 | USD 2.12 M | Vender |
65,874
-8,356
| -11% | -USD 286 k | ﹤0.01% | 2620 |
|
|
2022
Q2 | USD 2.2 M | Comprar |
74,230
+3,978
| +6% | +USD 115 k | ﹤0.01% | 2666 |
|
|
2022
Q1 | USD 1.98 M | Comprar |
70,252
+843
| +1% | +USD 31.4 k | ﹤0.01% | 2792 |
|
|
2021
Q4 | USD 3.2 M | Vender |
69,409
-1,812
| -3% | -USD 77.9 k | ﹤0.01% | 2612 |
|
|
2021
Q3 | USD 2.34 M | Vender |
71,221
-1,716
| -2% | -USD 53.3 k | ﹤0.01% | 2745 |
|
|
2021
Q2 | USD 2.56 M | Comprar |
72,937
+2,794
| +4% | +USD 95 k | ﹤0.01% | 2750 |
|
|
2021
Q1 | USD 2.54 M | Comprar |
70,143
+9,558
| +16% | +USD 299 k | ﹤0.01% | 2681 |
|
|
2020
Q4 | USD 1.76 M | Vender |
60,585
-13,659
| -18% | -USD 391 k | ﹤0.01% | 2676 |
|
|
2020
Q3 | USD 2.09 M | Vender |
74,244
-2,573
| -3% | -USD 76.6 k | ﹤0.01% | 2475 |
|
|
2020
Q2 | USD 2.48 M | Vender |
76,817
-189,279
| -71% | -USD 6.79 M | ﹤0.01% | 2371 |
|
|
2020
Q1 | USD 10.8 M | Vender |
266,096
-98,294
| -27% | -USD 5.23 M | ﹤0.01% | 1495 |
|
|
2019
Q4 | USD 22.5 M | Comprar |
364,390
+162,577
| +81% | +USD 10.8 M | 0.01% | 1370 |
|
|
2019
Q3 | USD 14.7 M | Vender |
201,813
-12,427
| -6% | -USD 930 k | ﹤0.01% | 1561 |
|
|
2019
Q2 | USD 17.6 M | Comprar |
214,240
+114,084
| +114% | +USD 8.11 M | ﹤0.01% | 1505 |
|
|
2019
Q1 | USD 7.06 M | Vender |
100,156
-14,300
| -12% | -USD 841 k | ﹤0.01% | 1769 |
|
|
2018
Q4 | USD 5.15 M | Vender |
114,456
-59,627
| -34% | -USD 3.13 M | ﹤0.01% | 1930 |
|
|
2018
Q3 | USD 9.8 M | Comprar |
174,083
+53,519
| +44% | +USD 3.28 M | ﹤0.01% | 1713 |
|
|
2018
Q2 | USD 8.05 M | Comprar |
120,564
+79,020
| +190% | +USD 4.93 M | ﹤0.01% | 1808 |
|
|
2018
Q1 | USD 2.42 M | Vender |
41,544
-249,406
| -86% | -USD 15.8 M | ﹤0.01% | 2438 |
|
|
2017
Q4 | USD 18.8 M | Comprar |
290,950
+269,072
| +1,230% | +USD 16.7 M | 0.01% | 1243 |
|
|
2017
Q3 | USD 1.15 M | Comprar |
21,878
+2,000
| +10% | +USD 95.4 k | ﹤0.01% | 2925 |
|
|
2017
Q2 | USD 930 k | Vender |
19,878
-109,385
| -85% | -USD 5.28 M | ﹤0.01% | 3062 |
|
|
2017
Q1 | USD 6.4 M | Vender |
129,263
-6,738
| -5% | -USD 378 k | ﹤0.01% | 1824 |
|
|
2016
Q4 | USD 8.24 M | Comprar |
136,001
+4,158
| +3% | +USD 254 k | ﹤0.01% | 1678 |
|
|
2016
Q3 | USD 8.75 M | Vender |
131,843
-25,295
| -16% | -USD 1.58 M | ﹤0.01% | 1588 |
|
|
2016
Q2 | USD 8.77 M | Comprar |
157,138
+136,541
| +663% | +USD 6.64 M | ﹤0.01% | 1512 |
|
|
2016
Q1 | USD 693 k | Vender |
20,597
-6,133
| -23% | -USD 208 k | ﹤0.01% | 3093 |
|
|
2015
Q4 | USD 1.21 M | Comprar |
26,730
+1,753
| +7% | +USD 75.5 k | ﹤0.01% | 2839 |
|
|
2015
Q3 | USD 987 k | Comprar |
24,977
+3,279
| +15% | +USD 187 k | ﹤0.01% | 2927 |
|
|
2015
Q2 | USD 1.35 M | Vender |
21,698
-210,658
| -91% | -USD 12.5 M | ﹤0.01% | 2897 |
|
|
2015
Q1 | USD 14.5 M | Comprar |
232,356
+223,148
| +2,423% | +USD 13.6 M | 0.01% | 1363 |
|
|
2014
Q4 | USD 520 k | Comprar |
9,208
+4,124
| +81% | +USD 182 k | ﹤0.01% | 3299 |
|
|
2014
Q3 | USD 144 k | Comprar |
5,084
+218
| +4% | +USD 6.53 k | ﹤0.01% | 3774 |
|
|
2014
Q2 | USD 168 k | Comprar |
+4,866
| Nuevas | +USD 153 k | ﹤0.01% | 3771 |
|
Otros fondos que tienen ANIP en su cartera
TCM
Posición de Invesco en ANIP: resumen de T2 2026
Invesco redujo su participación en ANI Pharmaceuticals (ANIP) en 4.7% durante T2 2026, al vender acciones por un valor estimado de USD 1.21 M, y conservó 309,233 acciones valuadas en USD 25.6 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1396.
Invesco reportó por primera vez una posición en ANIP en T2 2014 y la ha mantenido durante 49 trimestres desde entonces. Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank mantienen una posición en ANIP.
- Al cierre de T2 2026, Invesco tenía 309,233 acciones de ANI Pharmaceuticals con un valor de USD 25.6 M.
- Invesco vendió 15,116 acciones de ANI Pharmaceuticals en T2 2026, por un valor estimado de USD 1.21 M.
- ANI Pharmaceuticals representó ﹤0.01% de la cartera de Invesco en T2 2026 y fue su posición número 1396.
- Invesco reportó por primera vez una posición en ANI Pharmaceuticals en T2 2014 y la ha mantenido durante 49 trimestres desde entonces.
- Al cierre de T2 2026, 307 fondos que sigue Wall St. Rank tenían ANI Pharmaceuticals en cartera.
Según el Informe 13F de Invesco correspondiente a T2 2026, presentado el 14 ago 2026.